H.L. Ormond & Company Portfolio holdings
Top Buys
| 1 |
S&P Global
SPGI
|
+$1.25M |
| 2 |
Clarivate
CLVT
|
+$720K |
| 3 |
Tesla
TSLA
|
+$288K |
| 4 |
Intuitive Surgical
ISRG
|
+$214K |
| 5 |
Eli Lilly
LLY
|
+$202K |
Top Sells
| 1 |
Apple
AAPL
|
+$2.84M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$1.14M |
| 3 |
Axalta
AXTA
|
+$399K |
| 4 |
Abbott
ABT
|
+$222K |
| 5 |
Expeditors International
EXPD
|
+$221K |
Sector Composition
| 1 | Financials | 19.19% |
| 2 | Technology | 18.13% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Industrials | 10.34% |
| 5 | Healthcare | 6.56% |
Similar funds
H.L. Ormond & Company's Q1 2022 Portfolio in Review
As of Q1 2022, H.L. Ormond & Company held 109 positions worth $82M, down 3.8% from $85.3M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
H.L. Ormond & Company withdrew a net $3.1M in Q1 2022, closing 6 positions and reducing 59 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $1.14M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, H.L. Ormond & Company opened a new position in S&P Global worth $1.26M.
- H.L. Ormond & Company's largest Q1 2022 buy was S&P Global: 3,061 shares worth $1.26M.
- H.L. Ormond & Company added most to Clarivate in Q1 2022, an estimated $720K increase.
- H.L. Ormond & Company's biggest Q1 2022 reduction was Apple, cutting an estimated $2.84M.
- H.L. Ormond & Company fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $1.14M.
- H.L. Ormond & Company's ten largest holdings make up 23% of its $82M portfolio in Q1 2022.
- H.L. Ormond & Company opened 4 new positions and closed 6 in Q1 2022.
- H.L. Ormond & Company's portfolio value fell 3.8% quarter-over-quarter to $82M.
Based on H.L. Ormond & Company's 13F filing for Q1 2022, filed 11 May 2022.